eLife's transparent reporting form
We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments. Authors can upload supporting documentation to indicate the use of appropriate reporting guidelines for health-related research (see EQUATOR Network), life science research (see the BioSharing Information Resource), or the ARRIVE guidelines for reporting work involving animal research. Where applicable, authors should refer to any relevant reporting standards documents in this form.
If you have any questions, please consult our Journal Policies and/or contact us: editorial@elifesciences.org.
Sample-size estimation
• Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
For each experiment, sample-size estimation was determined based on effect size, and the assays were repeated following the convention. Permutation was performed when necessary to determine the false-discovery rates.
eLife Sciences Publications, Ltd is a limited liability non-profit non-stock corporation incorporated in the State of Delaware, USA, with company number 5030732, and is registered in the UK with company number FC030576 and branch number BR015634 at the address Westbrook Centre, Milton Road Cambridge CB4 1YG, UK | March 2019 2 All assays unless indicated were performed in triplicates. Soft agar experiments were performed in triplicates, and the graphs are plotted based on the mean and standard error of these experiments, as indicated in the figure legends. In vivo tumor, formation assays were performed across five individual mice injected in three sites. In vitro kinase assays were performed in three replicates, except Figure 6B , which was performed as biological replicates with two independent experiments carried out by different individuals at different time points. iTRAQ Phosphoproteomic experiments were performed as two independent biological and technical replicate experiments. SILAC was performed as two biological replicates. MudPIT was performed once, as indicated in the figure, and 
Statistical reporting
• Statistical analysis methods should be described and justified • Raw data should be presented in figures whenever informative to do so (typically when N per group is less than 10) • For each experiment, you should identify the statistical tests used, exact values of N, definitions of center, methods of multiple test correction, and dispersion and precision measures (e.g., mean, median, SD, SEM, confidence intervals; and, for the major substantive results, a measure of effect size (e.g., Pearson's r, Cohen's d) • Report exact p-values wherever possible alongside the summary statistics and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05.
Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
(For large datasets, or papers with a very large number of statistical tests, you may upload a single table file with tests, Ns, etc., with reference to sections in the manuscript.)
Group allocation
• Indicate how samples were allocated into experimental groups (in the case of clinical studies, please specify allocation to treatment method); if randomization was used, please also state if restricted randomization was applied • Indicate if masking was used during group allocation, data collection and/or data analysis Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Additional data files ("source data") • We encourage you to upload relevant additional data files, such as numerical data that are represented as a graph in a figure, or as a summary table • Where provided, these should be in the most useful format, and they can be Processed Proteomic data for Figures 1B, 3B , 3D, and 6B are provided as supplementary files. Source data for RNAseq analyses in Figure 7A have been uploaded to GEO, and the normalized RNAseq values and the genesets used in Figures 7A and 8C analyses are provided in the supplementary files. Source data, which include the quantification used to plot graphs for the figures, are provided with the manuscript.
